ADVFN US – Market Content Editor
-
Carrier Global Shares Slide After Q4 Earnings and Revenue Miss Forecasts
Carrier Global Corporation (NYSE:CARR) shares dropped more than 4% in premarket trading on Thursday after the company reported fourth-quarter results that fell short of analyst expectations, as weakness in residential markets outweighed strong growth in commercial HVAC demand. The climate and energy solutions provider reported adjusted earnings per share of $0.34 for the fourth quarter,…
-
Dorian LPG Shares Decline After Q3 Earnings Miss Market Expectations
Dorian LPG Ltd. (NYSE:LPG), a major operator of very large gas carriers (VLGCs), reported fiscal third-quarter 2026 results on Thursday that came in below analyst forecasts, sending its shares down more than 2% in premarket trading. The company posted adjusted earnings of $1.11 per share for the quarter ended December 31, 2025, missing analyst projections…
-
Linde Shares Slip as 2026 Outlook Falls Short Despite Strong Quarterly Results
Linde plc (NASDAQ:LIN) shares declined more than 2% in premarket trading on Thursday after the industrial gases company issued a full-year 2026 earnings outlook that disappointed investors, even as it delivered fourth-quarter results that exceeded expectations. The company reported adjusted earnings per share of $4.20 for the fourth quarter, slightly ahead of analyst forecasts of…
-
A newly-listed XR and AI technology company built for profitable growth
Consumers will play a leading role in tripling the value of the gaming industry from US$292.4 billion in 2025 to more than US$977.4 billion by 2035, but they are by no means the only driver behind expected exponential growth, given the enterprise space’s accelerating entry into the virtual world. We see this tailwind in action…
-
Alphabet Projects Up to $185 Billion in 2026 Capital Spending, Surpassing Market Forecasts
Alphabet (NASDAQ:GOOG) delivered quarterly results that exceeded analyst expectations on both earnings and revenue, while outlining a 2026 capital expenditure plan that significantly outpaced market projections. Despite the strong performance, Alphabet shares traded lower in U.S. premarket activity on Thursday following volatile movements during extended trading hours. The results arrive during a period of heightened…
-
Snap Shares Rise After Q4 Profit Beats Forecasts Despite User Growth Shortfall
Snap Inc (NYSE:SNAP) shares climbed roughly 6% in premarket trading on Thursday after the social media company reported fourth-quarter earnings that exceeded analyst expectations, even as user growth came in below forecasts and forward guidance remained cautious. The company reported adjusted earnings of $0.03 per share for the fourth quarter, outperforming analyst projections of a…
-
Arm Shares Fall in Premarket Trade Despite Earnings and Revenue Outperformance
Arm Holdings (NASDAQ:ARM) saw its American depositary receipts decline by more than 7% in U.S. premarket trading on Thursday, even after the semiconductor design company reported fiscal third-quarter results that exceeded analyst expectations. The company posted earnings per share of $0.43, surpassing market forecasts of $0.32. Revenue came in at $1.24 billion, slightly above the…
-
e.l.f. Beauty Shares Surge After Strong Quarterly Results and Upgraded Outlook
e.l.f. Beauty (NYSE:ELF) reported quarterly results that exceeded market expectations and increased its full-year guidance, driven by continued market share expansion and successful product introductions. Shares of the cosmetics company climbed more than 8% in premarket trading on Thursday following the announcement. The company posted third-quarter earnings per share of $1.24, significantly above the consensus…
-
Cigna Tops Q4 Profit Estimates as Revenue Growth Beats Expectations
Cigna (NYSE:CI) reported stronger-than-expected fourth-quarter results, with adjusted operating earnings reaching $8.08 per share, surpassing Bloomberg consensus forecasts of $7.88 per share. The health insurer posted adjusted revenue of $72.50 billion for the quarter, representing a 10% increase compared with the same period a year earlier and exceeding analyst expectations of $69.53 billion. Cigna’s medical…
-
Alvotech Advances Entyvio Biosimilar Program Following Successful Clinical Study
Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives. The randomized, double-blind trial compared AVT80 with Entyvio in healthy adult volunteers who received a single 108 mg subcutaneous dose. The research examined pharmacokinetics, safety, tolerability and immunogenic response of AVT80…